Evaluation of Glycemic Control after Sulfonylurea Withdrawal in Type 2 Diabetic Patients Treated with Combination of Oral Hypoglycemic Agents and Insulin: A Randomized Controlled Tria

Routine to Research Unit Siriraj Hospital (R2R)0 个研究点目标入组 32 人开始时间: 2013年4月22日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Type 2 diabetic patients, 30 to 75 year-old, who were treated with insulin in combination with SU, were enrolled in the study. All the subjects have been treated with insulin for at least 3 years and SU at half of the maximum doses or higher. All subjects had hemoglobin A1C levels (HbA1c) of less than 8.5% and stable insulin dosage (less than 10% adjustment) for at least three months prior to the enrollment. Patients who received metformin were included in the study

•Patients were excluded if they had other types of diabetes, received treatment with a combination of SU and once-daily insulin, or received thiazolidinediones or other medications which interfered with glucose or lipid metabolism. Other exclusion criteria included history of clinically significant heart disease (New York Heart Association Functional Classification greater than class II or abnormalities other than non-specific ST-T wave changes on the EKG), peripheral vascular disease, pulmonary disease, impaired renal function, poor blood pressure control, electrolyte abnormalities, and neuromuscular diseases.

发起方

Routine to Research Unit Siriraj Hospital (R2R)